Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: Its effect in systemic hypertension
- 1 August 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 54 (3) , 353-356
- https://doi.org/10.1016/0002-9149(84)90196-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Alpha-adrenoceptor blockade by labetalol during long-term dosingClinical Pharmacology & Therapeutics, 1983
- Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertensionEuropean Journal of Clinical Pharmacology, 1982
- Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.Published by Wiley ,1981
- STUDIES IN THE RAT ON BUCINDOLOL, A NEW ANTIHYPERTENSIVE AGENT WITH BETA-ADRENOCEPTOR BLOCKING PROPERTIES1981
- β-adrenoceptor and cardiovascular effects of MJ 13105 (Bucindolol) in anesthetized dogs and ratsEuropean Journal of Pharmacology, 1980
- BETA-ADRENOCEPTOR BLOCKING PROPERTIES OF MK-7611979
- Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.Journal of Clinical Investigation, 1975
- EFFECTS OF BETA-ADRENERGIC BLOCKADE DURING EXERCISE IN HYPERTENSIVE AND ISCHqMIC HEART-DISEASEThe Lancet, 1967